Literature DB >> 20042412

Making circadian cancer therapy practical.

Keith I Block1, Penny B Block, Susan Reynolds Fox, Jamie Stouffer Birris, April Y Feng, Michael de la Torre, Deva Nathan, Peter Tothy, Amanda K Maki, Charlotte Gyllenhaal.   

Abstract

Practical circadian therapy for the cancer patient involves 3 spheres of intervention-improving lifestyle, optimizing internal biochemical milieu, and adjusting treatment times. The potential value of improving overall circadian functioning is shown in the work of Mormont et al in which pronounced rest-activity rhythms were associated with better survival in colorectal cancer patients receiving chronomodulated chemotherapy. Lifestyle interventions that may improve circadian functioning involve diet, physical activity, and mind-body therapies. A diet that is anti-inflammatory and has appropriate carbohydrate intake, as well as regular meal timing, encourages normal circadian cycles. Adequate daytime physical activity encourages restful sleep, and morning light exposure during exercise may entrain melatonin rhythms. Meditation and other mind-body therapies can reduce anxiety and depression that may disrupt sleep. Aspects of the biochemical milieu that specifically disrupt circadian functioning are inflammation and stress hormones. Inflammation and cytokine disruption can be addressed with diet, herbs, and other natural substances. Chronomodulation of chemotherapy in a US clinical setting will be discussed. A series of 12 cases will be presented of patients who experienced grade 3 to 4 toxicities with various chemotherapy regimens for colorectal cancer. When rechallenged with the same regimens administered chronotherapeutically, none of the patients experienced grade 3 to 4 toxicity. Integrating all the above treatment modalities has the potential to improve both the quality of life and disease outcomes in cancer patients.

Entities:  

Mesh:

Year:  2009        PMID: 20042412     DOI: 10.1177/1534735409352028

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  6 in total

1.  Enhancing translation: guidelines for standard pre-clinical experiments in mdx mice.

Authors:  Raffaella Willmann; Annamaria De Luca; Michael Benatar; Miranda Grounds; Judith Dubach; Jean-Marc Raymackers; Kanneboyina Nagaraju
Journal:  Neuromuscul Disord       Date:  2011-07-06       Impact factor: 4.296

Review 2.  Targets, trafficking, and timing of cardiac autophagy.

Authors:  David Rotter; Beverly A Rothermel
Journal:  Pharmacol Res       Date:  2012-10-08       Impact factor: 7.658

3.  Advanced cancer patients in a randomized clinical trial of night-simulating eyeglasses observed to have a normal 24-h circadian rhythm during chemotherapy.

Authors:  Keith I Block; Charlotte Gyllenhaal; James F Grutsch; Penny B Block; Thomas Kazlausky; David Blask; Edward Carome; Justin Reynolds; Dinah Faith Q Huff; William Hrushesky
Journal:  SAGE Open Med       Date:  2022-05-23

4.  Increasing tumoral 5-fluorouracil concentrations during a 5-day continuous infusion: a microdialysis study.

Authors:  Inge R H M Konings; Stefan Sleijfer; Ron H J Mathijssen; Peter de Bruijn; Inge M Ghobadi Moghaddam-Helmantel; Linda M van Dam; Erik A C Wiemer; Jaap Verweij; Walter J Loos
Journal:  Cancer Chemother Pharmacol       Date:  2010-07-23       Impact factor: 3.333

5.  Expression of circadian clock gene human Period2 (hPer2) in human colorectal carcinoma.

Authors:  Yaping Wang; Luchun Hua; Chao Lu; Zongyou Chen
Journal:  World J Surg Oncol       Date:  2011-12-13       Impact factor: 2.754

6.  The Circadian System and Cancer: It's About Time!

Authors:  Keith I Block
Journal:  Integr Cancer Ther       Date:  2018-03       Impact factor: 3.279

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.